During GHT, HRT, and thyroid hormone therapy (four TS and one control), age appropriate serum concentrations of parameters (thyroid function, sex hormones, and growth factors) were ascertained and no overt liver dysfunction or dyslipidemia was detected. The gene discussed is TG; the disease is metabolic syndrome.